CHE
Chemed Corp
512.20$
+3.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +3.8% | +0.6% | +1.1% | +1.7% | +5.6% | +1.1% | -4.4% | +1.0% | +2.3% | +2.8% | +2.4% | – | |
| – | -1.1% | +7.5% | +1.2% | +1.7% | +2.4% | +6.1% | +0.8% | +2.3% | -2.4% | +5.8% | +2.2% | – | |
| – | +12.6% | -10.3% | +1.0% | +1.9% | +11.5% | -7.6% | -14.7% | -2.2% | +14.0% | -3.4% | +2.8% | – | |
| – | +0.8% | +15.4% | -14.0% | +2.4% | +2.2% | +1.3% | -5.9% | +6.4% | -0.3% | +8.4% | – | – | |
| – | +0.7% | +13.4% | -10.4% | -0.1% | +2.0% | +1.2% | -4.1% | -9.3% | -0.3% | +8.4% | +0.8% | – | |
| – | +28.3% | -35.1% | +21.8% | +4.6% | +23.6% | -16.8% | -28.1% | +9.8% | +34.7% | -16.0% | +5.5% | – | |
| – | -23.0% | +24.3% | +0.9% | -0.5% | +16.9% | -34.1% | +34.7% | +351.7% | -74.0% | -1.7% | +249.4% | – | |
| – | +23.9% | -26.9% | +11.1% | +7.7% | +18.9% | -20.4% | -25.7% | +17.5% | +26.2% | -15.7% | +2.8% | – | |
| – | +39.5% | -23.8% | +17.8% | +10.1% | +18.0% | -19.8% | -22.1% | +3.7% | +48.6% | -21.5% | +4.8% | – | |
| – | +20.1% | -27.8% | +9.0% | +6.9% | +19.2% | -20.6% | -26.8% | +22.4% | +19.5% | -13.6% | +2.1% | – | |
| – | +20.5% | -23.4% | +9.2% | +6.5% | +16.5% | -17.9% | -21.6% | +15.9% | +20.2% | -13.1% | -4.5% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.